Skip to main content

Table 1 Anthropometrical, clinical-laboratorial, and functional microvascular variables of 189 female subjects

From: Obesity, metabolic syndrome, impaired fasting glucose, and microvascular dysfunction: a principal component analysis approach

Variables

Mean±SD / Median [1st-3rd]

(Min-Max)

Age (years)

29 [20.5-49.5]

(12–64)

BMI (kg/m2)

30.5±7.1

(16.2-56.4)

Waist circumference (cm)

92.6±15.72

(60–146)

Systolic blood pressure (mmHg)

125.1±16

(80–182)

Diastolic blood pressure(mmHg)

74.8±10

(50–123)

Fasting plasma glucose (mmol/l)

4.86±0.55

(3.27-6.94)

Insulin (pmol/l)

76.06 [45.6-123.7]

(13.1-333.3)

Total cholesterol (mmol/l)

4.86±1.09

(1.68-8.10)

Triglycerides (mmol/l)

1.33±0.66

(0.30-3.83)

HDL cholesterol (mmol/l)

1.33±0.39

(0.46-2.53)

LDL cholesterol (mmol/l)

2.92±0.93

(0.73-5.82)

C-reactive protein (mg/l)

3.00 [1.15-6.85]

(0.3-20)

FCD (cap/mm2)

10.0 [7.6-14.4]

(4.3-29.16)

RBCV (mm/s)

0.30±0.08

(0.07-0.41)

RBCVmax (mm/s)

0.36±0.05

(0.12-0.48)

TRBCVmax (s)

8.37±2.29

(3–15)

  1. FCD, functional capillary density; RBCV, baseline red blood cell velocity; RBCVmax, peak red blood cell velocity; TRBCVmax, time taken to reach RBCVmax during the reactive hyperemia response.